Tumor target suggests personalized treatment for melanoma
Wednesday, June 16, 2010 - 00:40
in Health & Medicine
IKK-beta, a component of a pathway involved in melanoma development, may offer new leads for developing targeted melanoma therapies, researchers at Vanderbilt-Ingram Cancer Center report.